Cardiac Diseases Clinical Trial
— HYPNETOOfficial title:
Randomized Trial Comparing the Use of MEOPA (Equimolar Mixture of Nitrogen Protoxide and Oxygen)-Coupled Hypnosis Versus MEOPA Standard Care of Pain and Anxiety During Transesophageal Echocardiography (TEE) in Conscious Patients.
NCT number | NCT04398017 |
Other study ID # | 7351 |
Secondary ID | |
Status | Terminated |
Phase | N/A |
First received | |
Last updated | |
Start date | October 14, 2020 |
Est. completion date | August 12, 2022 |
Verified date | June 2023 |
Source | University Hospital, Strasbourg, France |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary purpose is to evaluate the impact of hypnosis coupled with MEOPA (Equimolar Mix-ture of Nitrogen Protoxide and Oxygen) on patient comfort when performing transoesophageal echocardiographies. Further studies on the use of MEOPA alone or the technique of hypnosis alone in the context of an TEE, would not be innovative in any way in view of previous studies or already in progress. However, service has led to perform TEEs several times by combining MEOPA and hypnosis. Doctors noted a clear reduction in induction time for hypnosis and satisfaction of the patient and operators. This association technique is very often used in pediatrics. According to one study, it seems that MEOPA increases the threshold of suggestibility and imagination. However suggestion and imagination are two essential notions of the hypnotic technique. To date, doctors have not found any other studies combining MEOPA and hypnosis for adults patients in the context of TEE. This leads to the following hypothesis: Is there a difference for the patient in terms of for the global management of pain and anxiety between an TEE performed under MEOPA with a standard support and TEE under MEOPA coupled with hypnosis with support standard? Secondary purposes are: 1. Compare patients' feelings / opinions: patients who have benefited from hypnosis associated with MEOPA versus patients who have been treated with MEOPA alone. 2. Compare patient stress: patients who have benefited from hypnosis associated with MEOPA versus patients who have benefited from MEOPA alone. 3. Compare the operators' feelings / opinions: procedures that have been performed under hypno-analgesia and MEOPA versus standard procedures under MEOPA alone. 4. Failed the TEE procedure
Status | Terminated |
Enrollment | 80 |
Est. completion date | August 12, 2022 |
Est. primary completion date | October 14, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient (male or female) of full age without upper age limit - Patient hospitalized on the site of the Nouvel Hôpital Civil - Strasbourg, with an indication of transesophageal echography with a diagnostic purpose of a cardiac pathology (transesophageal echography scheduled the day after or the very day of selection) - Patient affiliated to a social security health insurance scheme - Patient able to understand the objectives and risks related to the research and to give an informed consent dated and signed - For a woman of childbearing age: negative blood pregnancy test (test performed by the service as part of the care or diagnostic and therapeutic needs related to the patient's hospitalization). Exclusion Criteria: - Patient with a contraindication to the use of MEOPA - Patient with little or no understanding of French - Patient with hearing problems that do not allow hypnosis to occur - Patient with psychiatric disorders (schizophrenia, psychosis, melancholic depression, hysteria...) - Disoriented patients - Patient receiving the following treatments/management: ophthalmic gas centrally acting drugs: opiates, benzodiazepines and other psychotropic drugs (potentiation of effects). - Long-term anxiolytics - Premedications for transesophageal echocardiography by analgesics, Benzodiazepine, hydroxizine, antiemetics and gastric prokinetics or gabapentinoïdes (gabapentin, pregabaline) - Psychocorporal therapies or complementary therapies during the period of hospitalization (psychotherapy, meditation, acupuncture...) - Patient in exclusion period (determined by a previous or ongoing study), - Impossibility of giving the patient informed information (patient in an emergency situation, difficulties in understanding, etc.) - Pregnancy or breastfeeding reported by the patient - Patients under curatorship, guardianship, protection of justice - If the patient has an VAPS >8/10, the transesophageal echocardiography procedure and therefore its inclusion in the research will be postponed. |
Country | Name | City | State |
---|---|---|---|
France | CHU Strasbourg - France | Strasbourg |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Strasbourg, France |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Concomitant Measure of Pain and Anxiety | Measurements are made according to self-evaluation scales | Change from baseline Concomitant Measure of Pain and Anxiety at 10 minutes transesophageal echography |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00176657 -
The Use of HEMOBAG to Salvage Blood After Cardiac Surgery
|
Phase 2 | |
Completed |
NCT00027001 -
Qigong Therapy For Heart Device Patients
|
N/A | |
Completed |
NCT00661752 -
Protocol for Evaluation of Quarter-Time Cardiac Imaging: 5-Minutes Rest and 3-Minutes Stress Wide Beam Reconstruction (WBR) Versus Full-Time Filtered Back Projection (FBP)
|
N/A | |
Completed |
NCT00296738 -
123I-MIBG SPECT/CT for Assessment of Cardiac Sympathetic Innervation
|
Phase 0 | |
Completed |
NCT00293592 -
Dexamethasone for Cardiac Surgery Trial
|
N/A | |
Completed |
NCT01080781 -
Ephrin B1 Regulation in Human Right Appendage
|
N/A | |
Completed |
NCT00011310 -
Cardiopulmonary Effects of Particulate Exposure
|
N/A | |
Completed |
NCT02727634 -
Ultrapower; a Minimally Invasive Tool for Evaluation of Total Cardiac Power
|
N/A | |
Completed |
NCT01639313 -
Comparison of Nexfin Pulse Contour Analysis and Cardiac Magnetic Resonance Imaging for the Measurement of Cardiac Output
|
N/A | |
Completed |
NCT00945048 -
Non-Invasive Determination of Cardiac Output by Electrical Velocimetry
|
N/A | |
Completed |
NCT00281424 -
Increasing Walking Following Cardiac Rehabilitation
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06409481 -
Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA)
|
||
Completed |
NCT02723890 -
The Efficacy and Safety of Using the Novel Tyto Device
|
N/A | |
Completed |
NCT01165515 -
Endostatin Serum Levels During Bicycle Stress Test
|
N/A | |
Recruiting |
NCT05051254 -
Respiratory Muscles and Work of Breathing in Children
|
N/A | |
Completed |
NCT01683448 -
The Effect of Perioperative Medications on the Outcomes of Patients Undergoing Cardiac Surgery
|
||
Terminated |
NCT00229892 -
Incisions for Cardiac Surgery
|
N/A | |
Completed |
NCT02802254 -
Increasing Risk Perception of Physical Activity Using Patient-targeted Feedback.
|
Phase 2/Phase 3 | |
Completed |
NCT02159014 -
DanceFit Prime: A Dance Based Physical Activity and Nutritional Intervention for Primary Care - A Feasibility Study
|
N/A | |
Completed |
NCT00464126 -
The Use of Colloid Versus Crystalloid in Post-operative Pediatric Cardiac Patients for Fluid Resuscitation
|
N/A |